This Week in Cardiology

• Apr 11 2025 This Week in Cardiology  
  theheart.org on Medscape, April 11, 2025
• Apr 04 2025 This Week in Cardiology   Trials from the 2025 American College of Cardiology scientific sessions, including the WARRIOR, PROTECT TAVI, DAPATAVI, and SOUL are reviewed by John Mandrola, MD
  theheart.org on Medscape, April 04, 2025
• Mar 28 2025 This Week in Cardiology   Stopping oral anticoagulation after AF ablation, the core problem with paradoxes like the smoker’s paradox, chronic total occlusion PCI, and an ACC/EHRA preview are discussed by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, March 28, 2025
• Mar 21 2025 This Week in Cardiology   A large trial in cardiac pacing finally published, PVCs and cardiomyopathy, cannabis, CV risk and the danger of observational studies, and the tale of two disparate statin trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, March 21, 2025
• Mar 14 2025 This Week in Cardiology   Listener feedback, resistant hypertension, K-binders for MRA use in heart failure, nutritional epidemiology, and a positive study for vitamin D are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, March 14, 2025
• Mar 07 2025 This Week in Cardiology   Listener feedback on asymptomatic aortic stenosis (AS), transcatheter aortic valve replacement (TAVR) vs surgical aortic valve replacement (SAVR), coronary artery calcium (CAC), and revascularization for patients with ischemic LV dysfunction are discussed by John Mandrola, MD, in today's podcast.
  theheart.org on Medscape, March 07, 2025
• Feb 28 2025 This Week in Cardiology   The treatment of asymptomatic aortic stenosis, the move to composite endpoints in trials, IFR vs FFR and high-frequency low tidal volume ventilation for AF ablation are the topics John Mandrola, MD, discusses in today's podcast.
  theheart.org on Medscape, February 28, 2025
• Feb 21 2025 This Week in Cardiology   Blanking period after AF ablation, periprocedural MI after PCI in non-STEMI, predicting AF after ischemic stroke, and the proper standards for mitral valve repair in primary mitral regurgitation are the topics John Mandrola, MD, discusses in today’s podcast.
  theheart.org on Medscape, February 21, 2025
• Feb 14 2025 This Week in Cardiology   Silent cerebral embolism after LAAC, AI in ECG rhythm analysis, anti-thrombotic strategies in patients with AF and CAD, and subclinical AF are the topics John Mandrola, MD, covers in today's podcast.
  theheart.org on Medscape, February 14, 2025
• Feb 07 2025 This Week in Cardiology   Sugar-sweetened beverages, the epidemiology of driving after an ICD, BP measurements, and massive EBM lesson in EVT for acute stroke are the topics John Mandrola, MD, discusses in today's podcast.
  theheart.org on Medscape, February 07, 2025
• Jan 31 2025 This Week in Cardiology   Another negative AF ablation trial, predicting AF after stroke, the value of RCTs, troponin testing in the ED and surgical aortic valve choice are the topics John Mandrola, MD, discusses this week.
  theheart.org on Medscape, January 31, 2025
• Jan 24 2025 This Week in Cardiology   Familial hypercholesterolemia, cardiac arrest therapy, Factor XI inhibition, and tricuspid valve interventions are the topics John Mandroa, MD, discusses in this week’s podcast.
  theheart.org on Medscape, January 24, 2025
• Jan 17 2025 This Week in Cardiology   Renal denervation, the obesity paradox, JACC and the FINEARTS trial of finerenone in HFpEF, a setback for a PFA system, and coffee are the topics Jon Mandrola, MD, covers this week.
  theheart.org on Medscape, January 17, 2025
• Jan 10 2025 This Week in Cardiology   Alcohol and cancer, GLP-1 trial representativeness, diagnosing CAD, changing stroke rates in patients with AF, blanking periods after AF ablation are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, January 10, 2025
• Dec 20 2024 This Week in Cardiology   Listener feedback, multiple studies in AF ablation, a DANISH trial substudy of ICDs in NICM, and more data on eye complications of GLP-1 agonists are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 20, 2024
• Dec 13 2024 This Week in Cardiology   US doc's pay, the ticagrelor controversy and new RCTs, clopidogrel beats ASA, holding antiplatelets for non-cardiac surgery, and Prof Cleland and ASA dogma are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, December 13, 2024
• Dec 06 2024 This Week in Cardiology   Tirzepatide vs semaglutide in obesity; GLP1a use is complicated; HF outcomes; the misuse of meta-analyses in HF; and a breakthrough in HF care are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, December 06, 2024
• Nov 22 2024 This Week in Cardiology   An AHA review: the OPTION, SUMMIT, VANISH 2, SARAH, and CLEAR trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, November 22, 2024
• Nov 15 2024 This Week in Cardiology   Tirzepatide, AF screening, and an AHA preview, including VT ablation, LAAC at the time of AF ablation, BP targets, and GLP1 agonists in HF are the topics John Mandrola, MD, covers in today's podcast.
  theheart.org on Medscape, November 15, 2024
• Nov 08 2024 This Week in Cardiology   The EARLY TAVR trial, colchicine after MI, and the TRISCEND II trial of tricuspid valve replacement are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, November 08, 2024